Literature DB >> 32452055

Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma.

Xin Gao1, Jinlian Yang1, Yinyi Chen2.   

Abstract

Renal clear cell carcinoma (ccRCC) is the most common type of renal cell carcinoma, which has strong immunogenicity. A comprehensive study of the role of immune-related genes (IRGs) in ccRCC is of great significance in finding ccRCC treatment targets and improving patient prognosis. In this study, we comprehensively analyzed the expression of IRGs in ccRCC based on The Cancer Genome Atlas datasets. The mechanism of differentially expressed IRGs in ccRCC was analyzed by bioinformatics. In addition, Cox regression analysis was used to screen prognostic related IRGs from differentially expressed IRGs. We also identified a four IRGs signature consisting of four IRGs (CXCL2, SEMA3G, PDGFD, and UCN) through lasso regression and multivariate Cox regression analysis. Further analysis results showed that the four IRGs signature could effectively predict the prognosis of patients with ccRCC, and its predictive power is independent of other clinical factors. In addition, the correlation analysis of immune cell infiltration showed that this four IRGs signature could effectively reflect the level of immune cell infiltration of ccRCC. We also found that the expression of immune checkpoint genes CTLA-4, LAG3, and PD-1 in the high-risk group was higher than that in the low-risk group. Our research revealed the role of IRGs in ccRCC, and developed a four IRGs signature that could be used to evaluate the prognosis of patients with ccRCC, which will help to develop personalized treatment strategies for patients with ccRCC and improve their prognosis. In addition, these four IRGs may be effective therapeutic targets for ccRCC.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  bioinformatics; clear cell renal cell carcinoma; immune-related genes; prognosis; therapeutic target

Mesh:

Substances:

Year:  2020        PMID: 32452055     DOI: 10.1002/jcp.29796

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

1.  Identifying the role of transient receptor potential channels (TRPs) in kidney renal clear cell carcinoma and their potential therapeutic significances using genomic and transcriptome analyses.

Authors:  Jie Ren; Qihang Yuan; Jifeng Liu; Lei Zhong; Hanshuo Li; Guangzhen Wu; Feng Chen; Qizhen Tang
Journal:  BMC Med Genomics       Date:  2022-07-13       Impact factor: 3.622

2.  A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients.

Authors:  Patrick Terrematte; Dhiego Souto Andrade; Josivan Justino; Beatriz Stransky; Daniel Sabino A de Araújo; Adrião D Dória Neto
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

3.  Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer.

Authors:  Xin Gao; Jianping Cai
Journal:  Front Genet       Date:  2022-04-27       Impact factor: 4.772

4.  Gene expression-based immune infiltration analyses of renal cancer and their associations with survival outcome.

Authors:  Lei Chen; Liang Yin; Zilong Qi; Jinmin Li; Xinning Wang; Kun Ma; Xiangyang Liu
Journal:  BMC Cancer       Date:  2021-05-24       Impact factor: 4.430

5.  Artificial intelligence prediction model for overall survival of clear cell renal cell carcinoma based on a 21-gene molecular prognostic score system.

Authors:  Qiliang Peng; Yi Shen; Kai Fu; Zheng Dai; Lu Jin; Dongrong Yang; Jin Zhu
Journal:  Aging (Albany NY)       Date:  2021-03-03       Impact factor: 5.682

6.  Establishment of a Novel Risk Score System of Immune Genes Associated With Prognosis in Esophageal Carcinoma.

Authors:  Zhenghua Fei; Rongrong Xie; Zhi Chen; Junhui Xie; Yuyang Gu; Yue Zhou; Tongpeng Xu
Journal:  Front Oncol       Date:  2021-03-30       Impact factor: 6.244

7.  Immunological perspective on the malignant progression of renal clear cell carcinoma.

Authors:  Ji Liu; Wentao Zhang; Kang Lin; Wenchao Ma; Wei Li; Xudong Yao
Journal:  Ann Transl Med       Date:  2021-10

8.  Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma.

Authors:  Xiangui Meng; Hongwei Yuan; Weiquan Li; Wen Xiao; Xiaoping Zhang
Journal:  Int J Gen Med       Date:  2021-09-07

9.  Novel immune-related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.

Authors:  Libin Zhou; Hualong Fang; Min Yin; Huimin Long; Guobin Weng
Journal:  J Clin Lab Anal       Date:  2022-04-20       Impact factor: 3.124

10.  Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.

Authors:  Tiantian Liu; Hao Wu; Jianni Qi; Chengyong Qin; Qiang Zhu
Journal:  Cancer Med       Date:  2020-08-20       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.